In a recent study published in Cell, researchers examined the wealth of information available regarding the heterogeneity of tissue macrophages. They pursued a conceptual framework for better ...

The ORIGIN 3 trial is on track to announce topline results in the second quarter of 2025. These data were published in a manuscript in the Journal of the American Society of Nephrology. Get access to ...